comparemela.com

Page 2 - Startups Funding News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Africa PE and venture capital funding dips

Africa's considerable portion of private capital investment is concentrated in four major markets – South Africa, Kenya, Egypt and Nigeria.

South africaEuropean investment bankAfrica venture capitalStartups fundingAfrica startups

Here are top-20 startups on the rise in India in 2023, according to LinkedIn

Indian startups thrive despite economic challenges, with space tech, AI, and EV companies leading the way, says LinkedIn.

New delhiMadhya pradeshAndhra pradeshExponent energyIncome tax departmentIndia incSkyroot aerospaceAngel taxTop start upsHyderabad based skyroot aerospaceInformation securityVirtual realityTech startupsIndian startupsStartups fundingStartups 2023

nazara sbi mutual funds: Nazara Tech raises Rs 410 crore from SBI Mutual Fund

The firms board approved the issue of 5.7 million equity shares at 714/- per share to SBI Mutual Fund.

Uttar pradeshNitish mittersainProgramme in data scienceMagnum global fundIndian school of businessMutual fundOffering collegeMulticap fundTechnology opportunities fundNazara technologiesNikhil kamathGlobal fundTech processHigh value skillNazara sbi mutual fundsNazara tech funding

fintech funding: Indian fintech sector sees bleak first half of 2023 as funding drops 67%

In the first six months of 2023, Indian fintechs raised $1.4 billion, a significant drop from $4.3 billion in the same period last year.

Fintech fundingTracxn reportStartups fundingFunding newsIndia venture fundingEarly stage investments

US-based investor Janus Henderson marks down PharmEasy s valuation by half to $2 8 bn

Janus Henderson reduced the valuation of its holding in the firm by half which translates into an approximate valuation of $2.8 billion as of December 31, 2022.

Abu dhabiNeuberger bermanRatan tataJanus hendersonExchange commissionEconomic timesNew york basedAmansa capitalApah capitalPine labsTiger global backed upstoxPharmeasy valuationPharmeasy fundingHarmeasy funding roundHarmeasy investorsHarmeasy profitability

vimarsana © 2020. All Rights Reserved.